Division of Surgical Oncology, Brigham and Women's Hospital, Boston, Massachusetts; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts.
Division of Surgical Oncology, Brigham and Women's Hospital, Boston, Massachusetts.
J Surg Res. 2022 Nov;279:247-255. doi: 10.1016/j.jss.2022.06.003. Epub 2022 Jul 4.
Despite the advances in treatment, there are low rates of liver metastasectomy for colorectal cancer with liver metastasis (CRLM) in the United States. The aim of this study was to investigate the association between likelihood of liver metastasectomy for CRLM and seeking care at >1 versus 1 Commission on Cancer (CoC) hospital.
We performed a retrospective analysis of the National Cancer Database (2011-2017) for patients with CRLM. Patients were grouped based on seeking care at 1 CoC hospital or >1 CoC hospital. An adjusted multivariable Poisson regression interaction analysis was used to evaluate likelihood of liver metastasectomy for CRLM according to race and whether care was sought at >1 CoC hospital.
We identified 25,956 patients with CRLM without extra-hepatic disease. 23,088 (89.0%) patients visited 1 CoC hospital and 2868 (11.1%) visited >1 CoC hospital. Black patients were less likely to seek care at >1 CoC hospital (relative risk [RR] 0.68, confidence intervalCI 0.60-0.76, P < 0.001). Undergoing liver metastasectomy was associated with higher likelihood of seeking care at >1 CoC hospital (RR 1.27, CI 1.26-1.52, P < 0.001). Among patients who sought care at >1 CoC hospital, there was no significant difference between White and Black patients undergoing liver metastasectomy (RR 0.86, 95% CI 0.71-1.04, P = 0.11).
Patients with CRLM who sought care at >1 CoC hospital were more likely to undergo a liver metastasectomy. Among White and Black patients who sought care at >1 CoC hospital, there was no difference in likelihood of undergoing a liver metastasectomy.
尽管治疗取得了进展,但美国结直肠癌伴肝转移(CRLM)患者接受肝转移切除术的比例仍然较低。本研究旨在探讨 CRLM 患者是否选择在多家癌症委员会(CoC)认证医院接受治疗与接受肝转移切除术的可能性之间的关系。
我们对 2011 年至 2017 年国家癌症数据库(National Cancer Database)中的 CRLM 患者进行了回顾性分析。患者根据是否在一家 CoC 医院或多家 CoC 医院就诊进行分组。采用调整后的多变量泊松回归交互分析,根据种族和是否在多家 CoC 医院就诊,评估 CRLM 患者行肝转移切除术的可能性。
我们共纳入 25956 例无肝外疾病的 CRLM 患者。23088 例(89.0%)患者在一家 CoC 医院就诊,2868 例(11.1%)患者在多家 CoC 医院就诊。黑人患者在多家 CoC 医院就诊的可能性较低(相对风险[RR]0.68,95%置信区间[CI]0.60-0.76,P<0.001)。行肝转移切除术与在多家 CoC 医院就诊的可能性较高相关(RR 1.27,95%CI 1.26-1.52,P<0.001)。在多家 CoC 医院就诊的患者中,白人患者和黑人患者行肝转移切除术的可能性没有显著差异(RR 0.86,95%CI 0.71-1.04,P=0.11)。
在 CRLM 患者中,在多家 CoC 医院就诊的患者更有可能接受肝转移切除术。在在多家 CoC 医院就诊的白人患者和黑人患者中,行肝转移切除术的可能性没有差异。